]>
IRCT20190219042755N1 IRCT 2021-02-06 Arak University of Medical Sciences Antibiotic prophylaxis with doxycycline vs azithromycin prior to hysterosalpingography - Evaluation of Prophylactic efficacy and side effects of azithromycin versus doxycycline prior to hysterosalpingography in sub fertile women 2021-01-14 anticipated 180 Complete https://irct.ir/trial/53526 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Simple randomization: Patients received doxycycline on even days and azithromycin on odd days, Blinding description: Participants: Provide tablets in unnamed medicine boxes for patients Data Analyzer: Provide raw data based on code one (azithromycin) and code two (doxycycline). 4 pelvic inflammatory disease. Intervention 1: Control group: patients treated with doxycycline. Intervention 2: Intervention group: patients treated with azithromycin. Yes - There is a plan to make this available What will be shared: All individual data will be published after coding. When: Access starts 6 months after the results are published To whom: All people in the field of medicine and treatment are able to benefit from information Conditions: There are no access restrictions. Where to obtain: Send email to the author Nz.rezaei4000@gmail.com How to obtain: One week after receiving the email Comments:
public Zahra Rezaei
Valiasr hospital. next to valiasr square. Arak city, iran
Arak Iran (Islamic Republic of) 3814957558 +98 86 3222 2003 Nz.rezaei4000@gmail.com Arak University of Medical Sciences scientific Zahra Rezaei
Valiasr hospital. next to valiasr square. Arak city, iran
Arak Iran (Islamic Republic of) 3814957558 +98 86 3222 2003 nz.rezaei4000@gmail.com Arak University of Medical Sciences Iran (Islamic Republic of) Sub fertile women 15-35 year old Do not take any antibiotics during the week before the procedure 15 years 35 years Female History of severe drug allergy to doxycycline and azithromycin (anaphylactic shock, cutaneous rash, and complications leading to hospitalization) Active pelvic inflammation Previously known history of pelvic infection Known case of endometriosis History of ectopic pregnancy History of fallopian tube surgery Pregnancy Severe uterine bleeding N73.9 Female pelvic inflammatory disease, unspecified Treatment - Drugs Treatment - Drugs Control group: patients treated with doxycycline Intervention group: patients treated with azithromycin Pelvic inflammatory disease is defined as a clinical diagnosis including fever and chills. Vaginal discharge. Abdominal pain. Timepoint: Evaluation of patients' symptoms for pelvic inflammatory infection 2 weeks after hysterosalpingography and in case of patients with symptoms of pelvic inflammatory infection , Follow up patients for the next 2 weeks after symptoms resolve. Method of measurement: Visit the doctor by phone and check the patient's symptoms and if any of the symptoms are fever and chills, vaginal discharge and hypogastric pain, see a gynecologist and after examining the patient and prescribing appropriate treatment, follow up patients for 2 weeks until complete relief of symptoms. Drug side effects, nausea and vomiting. Timepoint: Within two weeks after hysterosalpingography. Method of measurement: Phone call by the doctor and questions from the patient. Drug side effects, diarrhea. Timepoint: Within two weeks after hysterosalpingography. Method of measurement: Phone call by the doctor and questions from the patient. Drug side effects, abdominal pain. Timepoint: Within two weeks after hysterosalpingography. Method of measurement: Phone call by the doctor and questions from the patient. Arak University of Medical Sciences Approved 2019-10-29 Ethics committee of arak University of Medical Sciences Arak. The Great Prophet University Complex. Arak Markazi Iran (Islamic Republic of)